Support Alert

Company-Led Drug Alert: Imatinib 400mg Capsules PL 36390/0180

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led recall for Imatinib 400mg Capsules.


Cipla (EU) Limited has informed the MHRA that there is an error on the Patient Information Leaflet (PIL) for Imatinib 400mg Capsules: the dosage information for the indication CML is incorrect.


Further details of the alert, including the affected batch, and action to take are available on the MHRA website.

Loading...

Email newsletter

Want the latest pharmacy news and updates straight to your inbox?

Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.

Sign Up